{"title": "Modern Drug Discovery: November 2004", "author": null, "url": null, "hostname": null, "description": "Modern Drug Discovery focuses on emerging trends and technologies in such areas as: genomics, proteomics, bioinformatics, combinatorial chemistry, and high throughput screening.", "sitename": null, "date": "2004-01-01", "cleaned_text": "| | Content in Context [Research politics](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104editorial.pdf) (32 KB PDF) by Ann M. Thayer [New and Noteworthy](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104news.pdf) (124 KB PDF) RNAi to eye Double-binding inhibitor Smallpox progress Airway alliance Tumor-slowing duo Dendrimer detox Eye of the beholder Stent assessment Focus on Business Diseases and Disorders [Epilepsy](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104diseases.pdf) (56 KB PDF) by Julie L. McDowell With many treatments available, the pipeline for new drugs to treat this enigmatic disease is thin. Rules and Regulators [SEC and FDA: Tag-team regulating](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104rules.pdf) (72 KB PDF) by David Filmore Securities and Exchange Commission investigators are using whatever tools they can to monitor drug company disclosures. Clinical Trials Track [Thalidomide therapy?](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104clinical.pdf) (64 KB PDF) by David Filmore The infamous morning sickness drug and its derivatives are the focus of clinical trials in multiple disease areas. Applications Notebook [This just in](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104applications.pdf) (108 KB PDF) by Jared Browning and Brian Almond Researchers rely on reporter systems to analyze gene expression in cell-based assays. Sites and Software [Identifying the protein](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104sites.pdf) (84 KB PDF) by D. C. Anderson New developments in software for mass spectrometry-based proteomics The Tool Box [Sedimentation for success](http://pubs.acs.org/subscribe/archive/mdd/v07/i11/pdf/1104toolbox.pdf) (96 KB PDF) by Michelle Arkin Characterizing small-molecule/protein interactions by sedimentation analysis helps validate lead series early in the drug discovery process. "}